Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 147758

1.

Generation of a novel long-acting thymosin alpha1-Fc fusion protein and its efficacy for the inhibition of breast cancer in vivo.

Shen X, Li Q, Wang F, Bao J, Dai M, Zheng H, Lao X.

Biomed Pharmacother. 2018 Sep 19;108:610-617. doi: 10.1016/j.biopha.2018.09.064. [Epub ahead of print]

PMID:
30243095
2.
3.

[Recurrent bleeding of a duodenal ulcer in a 55-year-old man after heart transplantation].

Vogel Y, Wolff I, Zobel C, Hildenbrand R.

Internist (Berl). 2018 Sep 21. doi: 10.1007/s00108-018-0492-4. [Epub ahead of print] German.

PMID:
30242430
4.

The effects of CD14 and IL-27 on induction of endotoxin tolerance in human monocytes and macrophages.

Petes C, Mintsopoulos V, Finnen RL, Banfield BW, Gee K.

J Biol Chem. 2018 Sep 21. pii: jbc.RA118.003501. doi: 10.1074/jbc.RA118.003501. [Epub ahead of print]

PMID:
30242126
5.

Disseminated nocardiosis with cerebral and subcutaneous lesions on low-dose prednisone.

Mahajan KR.

Pract Neurol. 2018 Sep 21. pii: practneurol-2018-002038. doi: 10.1136/practneurol-2018-002038. [Epub ahead of print]

PMID:
30242096
6.

Understanding Biofilms and Novel Approaches to the Diagnosis, Prevention, and Treatment of Medical Device-Associated Infections.

Wi YM, Patel R.

Infect Dis Clin North Am. 2018 Sep 18. pii: S0891-5520(18)30062-X. doi: 10.1016/j.idc.2018.06.009. [Epub ahead of print] Review.

PMID:
30241715
7.

Development of a BiTE®-mediated CD8+ cytotoxic T-lymphocyte activity assay to assess immunomodulatory potential of drug candidates in Cynomolgus macaque.

Frank B, Wei YL, Kim KH, Guerrero A, Lebrec H, Balazs M, Wang X.

J Immunotoxicol. 2018 Dec;15(1):119-125. doi: 10.1080/1547691X.2018.1486342.

PMID:
30241454
8.

Review of the Clinical Experiences of Feeding Infants Formula Containing the Human Milk Oligosaccharide 2'-Fucosyllactose.

Reverri EJ, Devitt AA, Kajzer JA, Baggs GE, Borschel MW.

Nutrients. 2018 Sep 21;10(10). pii: E1346. doi: 10.3390/nu10101346. Review.

PMID:
30241407
9.

Combination antitumor immunotherapy with VEGF and PIGF siRNA via systemic delivery of multi-functionalized nanoparticles to tumor-associated macrophages and breast cancer cells.

Song Y, Tang C, Yin C.

Biomaterials. 2018 Sep 11;185:117-132. doi: 10.1016/j.biomaterials.2018.09.017. [Epub ahead of print]

PMID:
30241030
10.

Computer-based intensity measurement assists pathologists in scoring PTEN immunohistochemistry - Clinical associations in NSCLC patients of the ETOP Lungscape cohort.

Rulle U, Tsourti Z, Casanova R, Deml KF, Verbeken E, Thunnissen E, Warth A, Cheney R, Sejda A, Speel EJ, Madsen LB, Nonaka D, Navarro A, Sansano I, Marchetti A, Finn SP, Monkhorst K, Kerr KM, Haberecker M, Wu C, Zygoura P, Kammler R, Geiger T, Gendreau S, Schulze K, Vrugt B, Wild P, Moch H, Weder W, Ciftlik AT, Dafni U, Peters S, Bubendorf L, Stahel RA, Soltermann A.

J Thorac Oncol. 2018 Sep 18. pii: S1556-0864(18)33053-3. doi: 10.1016/j.jtho.2018.08.2034. [Epub ahead of print]

PMID:
30240851
11.

Trans-maternal Helicobacter pylori exposure reduces allergic airway inflammation in offspring through regulatory T-cells.

Kyburz A, Fallegger A, Zhang X, Altobelli A, Artola-Boran M, Borbet T, Urban S, Paul P, Münz C, Floess S, Huehn J, Cover TL, Blaser MJ, Taube C, Müller A.

J Allergy Clin Immunol. 2018 Sep 18. pii: S0091-6749(18)31297-1. doi: 10.1016/j.jaci.2018.07.046. [Epub ahead of print]

PMID:
30240703
12.

Combining Tumor Microenvironment Modulating Nanoparticles with Doxorubicin to Enhance Chemotherapeutic Efficacy and Boost Antitumor Immunity.

Amini MA, Abbasi AZ, Cai P, Lip H, Gordijo CR, Li J, Chen B, Zhang L, Rauth AM, Wu XY.

J Natl Cancer Inst. 2018 Sep 14. doi: 10.1093/jnci/djy131. [Epub ahead of print]

PMID:
30239773
13.

« Immunosuppression » is Inappropriately Qualifying the Immune Status of Septic and Sirs Patients.

Cavaillon JM, Giamarellos-Bourboulis EJ.

Shock. 2018 Sep 19. doi: 10.1097/SHK.0000000000001266. [Epub ahead of print]

PMID:
30239420
14.

Anal High-Grade Squamous Intraepithelial Lesions in Pharmacologically Immunocompromised Patients Followed in a Referral Center.

Albuquerque A, Cappello C, Cuming T, De Masi A, Bowring J, Rosenthal AN, Nathan M.

Dis Colon Rectum. 2018 Sep 19. doi: 10.1097/DCR.0000000000001214. [Epub ahead of print]

PMID:
30239398
15.

Antisynthetase syndrome pathogenesis: knowledge and uncertainties.

Gallay L, Gayed C, Hervier B.

Curr Opin Rheumatol. 2018 Sep 2. doi: 10.1097/BOR.0000000000000555. [Epub ahead of print]

PMID:
30239350
16.

Uveitis causes according to immune status of patients.

Rothova A, Hajjaj A, de Hoog J, Thiadens AAHJ, Dalm VASH.

Acta Ophthalmol. 2018 Sep 21. doi: 10.1111/aos.13877. [Epub ahead of print]

PMID:
30239127
17.

Management of anti-HBc-positive patients with rheumatic diseases treated with disease-modifying antirheumatic drugs-a single-center analysis of 2054 patients.

Schwaneck EC, Krone M, Kreissl-Kemmer S, Weißbrich B, Weiss J, Tony HP, Gadeholt O, Schmalzing M, Geier A.

Clin Rheumatol. 2018 Sep 20. doi: 10.1007/s10067-018-4295-8. [Epub ahead of print]

PMID:
30238380
18.

Mechanisms of sepsis-induced immunosuppression and immunological modification therapies for sepsis.

Ono S, Tsujimoto H, Hiraki S, Aosasa S.

Ann Gastroenterol Surg. 2018 Jul 24;2(5):351-358. doi: 10.1002/ags3.12194. eCollection 2018 Sep. Review.

PMID:
30238076
19.

Platelet Gene Therapy Promotes Targeted Peripheral Tolerance by Clonal Deletion and Induction of Antigen-Specific Regulatory T Cells.

Luo X, Chen J, Schroeder JA, Allen KP, Baumgartner CK, Malarkannan S, Hu J, Williams CB, Shi Q.

Front Immunol. 2018 Sep 6;9:1950. doi: 10.3389/fimmu.2018.01950. eCollection 2018.

PMID:
30237796
20.

Helicobacter pylori infection and inflammatory bowel disease: a crosstalk between upper and lower digestive tract.

Yu Y, Zhu S, Li P, Min L, Zhang S.

Cell Death Dis. 2018 Sep 20;9(10):961. doi: 10.1038/s41419-018-0982-2.

PMID:
30237392

Supplemental Content

Loading ...
Support Center